Purpose of Review

Headache affects and disables at least 1 billion people worldwide. Patients and providers seek new therapies to relieve headache without the side effects and financial burden of current treatments. This narrative review highlights recent treatment advances in integrative headache medicine: nutraceuticals and behavioral therapies.

Recent Findings

Growing use of complementary and alternative medicine (CAM) therapies for headache (riboflavin, coenzyme Q10, magnesium, vitamin D, melatonin) alongside mainstream treatments is increasing with improving evidence of quality, safety, and tolerability. Increasing interest in medical cannabis is tempered by lack of evidence regarding safety and efficacy. Behavioral therapies including cognitive behavioral therapy (CBT), biofeedback, mindfulness-based stress reduction (MBSR), and acceptance and commitment therapy (ACT) improve patient resiliency and self-efficacy outcomes and reduce disability.

Summary

The body of evidence for nutraceutical and behavioral CAM interventions for headache continues to grow and improve in quality. Providers and patients should educate themselves regarding CAM therapies as part of integrative headache management. Future studies should examine combinatorial trials of CAM therapies against current standards of headache care.

中文翻译：

---

营养保健品和头痛的行为疗法

审查目的

头痛影响着全世界至少10亿人并使其失去能力。患者和提供者寻求新的疗法来缓解头痛，而又没有目前疗法的副作用和经济负担。这篇叙述性评论重点介绍了综合性头痛药的最新治疗进展：营养保健品和行为疗法。

最近的发现

随着质量，安全性和耐受性证据的改善，用于头痛（核黄素，辅酶Q10，镁，维生素D，褪黑激素）的补充和替代药物（CAM）治疗越来越多地与主流疗法一起使用。由于缺乏有关安全性和有效性的证据，人们对医用大麻的兴趣日益增加。行为疗法包括认知行为疗法（CBT），生物反馈，正念减轻压力（MBSR）以及接受和承诺疗法（ACT），可提高患者的适应能力和自我效能，并减少残疾。

概括

头痛的营养保健和行为CAM干预的证据不断增长，质量不断提高。提供者和患者应接受有关CAM治疗的自我教育，这是综合性头痛治疗的一部分。未来的研究应对照目前头痛治疗的标准，检查CAM治疗的组合试验。